DTIL — Precision Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Precision Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	144	190	117	86.3	116
Net Total Accounts Receivable
Net Total Receivables	0.488	0.72	12.8	1.7	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	162	199	136	95	119
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	29.3	23.2	14.6	10.2	7.23
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	211	238	160	136	154
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	36	59.7	50	15	8.91
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	120	178	141	80	62.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	91.2	60.4	18.9	56.4	92.2
Total Liabilities & Shareholders' Equity	211	238	160	136	154
Total Common Shares Outstanding